文献速递治疗药物监测与药物基因组学

代谢性骨病的遗传学方法

Genetic approaches to metabolic bone diseases.
PubMed 文献 · Br J Clin Pharmacol · 2018-11-28

代谢性骨病包括一组以骨骼稳态改变为特征的疾病,常伴有钙、磷或维生素D代谢物循环浓度异常。这些疾病通常具有遗传基础,可为单基因(生殖系或体细胞突变)或多基因/寡基因(涉及多个基因变异)疾病。识别家族性单基因病对患者及受累亲属的及时诊治具有临床重要性,诊断需基于详细病史、体格检查、实验室和骨骼影像学评估,并合理选择与解读分子遗传学检测。

要点

  • 代谢性骨病常伴钙、磷或维生素D代谢物异常,需警惕遗传基础。
  • 单基因病(生殖系或体细胞突变)外显率高,多基因/寡基因病变异效应小且受环境因素影响。
  • 识别家族性单基因病有助于患者及受累亲属的及时诊治。

核心结论

  • 代谢性骨病具有遗传基础,可为单基因、寡基因或多基因疾病。
  • 识别家族性单基因病对患者及受累亲属的及时诊治具有临床重要性。

研究设计与样本

  • 综述,阐述代谢性骨病的遗传学基础及诊断方法。

主要发现

  • 代谢性骨病常伴有钙、磷或维生素D代谢物循环浓度异常。
  • 单基因病由生殖系或体细胞单基因突变引起,外显率高。
  • 寡基因或多基因病涉及多个基因变异,每个变异效应较小,并受环境因素影响。

关键数值与推荐

  • 诊断单基因代谢性骨病需系统评估:详细病史和体格检查,随后进行适当的实验室和骨骼影像学评估。
  • 临床医生需了解日益增多且复杂的分子遗传学检测,以确保合理使用和解读。

临床怎么用

  • 对疑似代谢性骨病患者,应系统采集病史、体格检查,并安排实验室和骨骼影像学评估。
  • 识别家族性单基因病后,应对患者及受累亲属及时开展诊治。
  • 选择分子遗传学检测时,需理解其适用性和结果解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metabolic bone diseases comprise a diverse group of disorders characterized by alterations in skeletal homeostasis, and are often associated with abnormal circulating concentrations of calcium, phosphate or vitamin D metabolites. These diseases commonly have a genetic basis and represent either a monogenic disorder due to a germline or somatic single gene mutation, or an oligogenic or polygenic disorder that involves variants in more than one gene. Germline single gene mutations causing Mendelian diseases typically have a high penetrance, whereas the genetic variations causing oligogenic or polygenic disorders are each associated with smaller effects with additional contributions from environmental factors. Recognition of familial monogenic disorders is of clinical importance to facilitate timely investigations and management of the patient and any affected relatives. The diagnosis of monogenic metabolic bone disease requires careful clinical evaluation of the large diversity of symptoms and signs associated with these disorders. Thus, the clinician must pursue a systematic approach beginning with a detailed history and physical examination, followed by appropriate laboratory and skeletal imaging evaluations. Finally, the clinician must understand the increasing number and complexity of molecular genetic tests available to ensure their appropriate use and interpretation.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Hannan FM, Newey PJ, Whyte MP, et al. Genetic approaches to metabolic bone diseases. Br J Clin Pharmacol. 2018. PMID: 30357886. doi:10.1111/bcp.13803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。